WHO International Standards and Reference Preparations for Cytokines and Growth Factors

August 9, 2019

The ability to quantify the activity of cytokines is an essential part of experimental and clinical investigation and is largely dependent upon the availability of suitable cytokine standards and reference reagents.

The International Cytokine and Interferon Society (ICIS) Standards Committee was established to make recommendations regarding interferon and cytokine standards and standardization to the ICIS membership, and thereby to the international cytokine scientific community. The Committee works closely with the World Health Organization (WHO), the National Institute for Biological Standards and Control (NIBSC), the U.S. National Institutes of Health (NIH), the Biodefense and Emerging Infections Resources Repository (BEI Resources), pharmaceutical manufacturers, and regulatory agencies.

The Committee includes members from several of these organizations. The role that the Committee plays as a source of information and recommendations to the ICIS membership, and to the international cytokine scientific community as a whole, is very much dependent upon suitable standards and reference materials made available by the NIBSC. Similarly, the Standardization and Nomenclature Committee of the ICIS reviews the need for cytokine standards and their usage. With the expanding role of cytokines and growth factors in the development and manufacture of biotechnology derived products e.g., monoclonal antibodies targeting cytokines/growth factors, biosimilar medicines, cell and/or gene therapy products, the need for suitable standards is increasing.

A comprehensive Table with WHO International Standards (IS), WHO reference reagents (WRR) and other cytokine and growth factor standards available from the NIBSC is available here.

ISs and WRRs are publicly available reference standards with defined units (International Unit) established by the WHO Expert Committee on Biological Standardization. Lyophilised and formulated to ensure long term stability, they serve as ‘primary’ standards for bioactivity and for calibration of secondary reference standards. The use of IS and WRR to calibrate commercially available or laboratory made reagents including immunoassays where feasible, as per WHO recommendations, facilitates comparisons of data between assays, different laboratories, and individual studies allowing global harmonisation.

Check out the full document here.

More News

2021 Edition: Day of Immunology

June 17, 2021

2021 International Day of Immunology

June 7, 2021

Chinese Society for Immunology (CSI) Training Courses in 2020

March 4, 2021

Michelson Prizes

March 4, 2021

FUNDING OPPORTUNITY FROM IUIS AND FOCIS FOR IMMUNOLOGISTS FROM THE DEVELOPING WORLD – For Participation in Virtual Advanced Course in Basic & Clinical Immunology on March 1-3, 2021, USA

February 17, 2021

New Webinar Series: Immunology without Borders

February 2, 2021

IUIS/AAI AWARDS: SUMMER COURSES in IMMUNOLOGY

January 18, 2021

News from ICLAS

December 17, 2020

GEC Statement on the Publication “The association between early career informal mentorship in academic collaborations and junior author performance”

December 16, 2020